Venus Remedies gains DCGI approval for trials on molecule

05/6/2009 | RTT News

Venus Remedies has received clearance from the Drugs Controller General of India to undertake Phase I clinical trials for VRP 1620, a molecule administered through injection that can be used to diagnose solid tumors in humans. If used with PET/CT, the drug might help pinpoint cancer stage and aid oncologists in determining the right course of therapy and monitoring treatment progress.

View Full Article in:

RTT News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT